3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
20
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
33
Carcinoma, Non-Small-Cell Lung
6
Uveal Melanoma
5
Skin Neoplasms
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Kidney Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Mycosis Fungoides
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urticaria Pigmentosa
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Pruritus
1
Pancreatic Neoplasms
1
Interventions
pembrolizumab
19
Nivolumab
16
Cyclophosphamide
9
Specimen Handling
7
Ipilimumab
7
atezolizumab
6
fludarabine
5
Magnetic Resonance Spectroscopy
5
durvalumab
3
avelumab
3
X-Rays
3
Biopsy
3
ulixertinib
2
sargramostim
2
poly ICLC
2
lenvatinib
2
epacadostat
2
enzalutamide
2
cemiplimab
2
cabozantinib
2
budigalimab
2
aldesleukin
2
Trastuzumab
2
Sirolimus
2
Paclitaxel
2
Melphalan
2
Interleukin-2
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Docetaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Blood Specimen Collection
×
Dermatologic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled